Review



polyclonal rabbit anti-glut3 primary antibody  (Thermo Fisher)


Bioz Verified Symbol Thermo Fisher is a verified supplier
Bioz Manufacturer Symbol Thermo Fisher manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Thermo Fisher polyclonal rabbit anti-glut3 primary antibody
    Tau pathology switches the energy metabolism to fatty acid oxidation. A-B Immunofluorescence staining of neuron-specific <t>glucose</t> <t>transporter</t> <t>3</t> <t>(GLUT3)</t> in the medulla oblongata from control and transgenic animals. Representative images of GLUT3 (green), NeuN (red), and DAPI staining (blue). C Representative images of 8-month-old control and transgenic animals. Scale bar 20 μm. D . Quantification of GLUT3 mean fluorescence intensity in brain tissue. Quantification of relative fluorescent intensity showed a decrease of GLUT3 in transgenic animals (8-months old animals: CN: 25.07 ± 1.43, Tg: 20.91 ± 0.54; p = 0.035; 10-month-old animals: CN: 28.37 ± 1.03, Tg: 22.36 ± 1.67; p = 0.022; n = 5; mean ± SD, student’s t-test with p-value). E Changes of long-chain, hydroxylated, short-chain ACs and free carnitine in brain tissue of control and transgenic rats (data are presented as median intensities with 95% confidence intervals)
    Polyclonal Rabbit Anti Glut3 Primary Antibody, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/polyclonal rabbit anti-glut3 primary antibody/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    polyclonal rabbit anti-glut3 primary antibody - by Bioz Stars, 2026-03
    90/100 stars

    Images

    1) Product Images from "Changes in lipid metabolism track with the progression of neurofibrillary pathology in tauopathies"

    Article Title: Changes in lipid metabolism track with the progression of neurofibrillary pathology in tauopathies

    Journal: Journal of Neuroinflammation

    doi: 10.1186/s12974-024-03060-4

    Tau pathology switches the energy metabolism to fatty acid oxidation. A-B Immunofluorescence staining of neuron-specific glucose transporter 3 (GLUT3) in the medulla oblongata from control and transgenic animals. Representative images of GLUT3 (green), NeuN (red), and DAPI staining (blue). C Representative images of 8-month-old control and transgenic animals. Scale bar 20 μm. D . Quantification of GLUT3 mean fluorescence intensity in brain tissue. Quantification of relative fluorescent intensity showed a decrease of GLUT3 in transgenic animals (8-months old animals: CN: 25.07 ± 1.43, Tg: 20.91 ± 0.54; p = 0.035; 10-month-old animals: CN: 28.37 ± 1.03, Tg: 22.36 ± 1.67; p = 0.022; n = 5; mean ± SD, student’s t-test with p-value). E Changes of long-chain, hydroxylated, short-chain ACs and free carnitine in brain tissue of control and transgenic rats (data are presented as median intensities with 95% confidence intervals)
    Figure Legend Snippet: Tau pathology switches the energy metabolism to fatty acid oxidation. A-B Immunofluorescence staining of neuron-specific glucose transporter 3 (GLUT3) in the medulla oblongata from control and transgenic animals. Representative images of GLUT3 (green), NeuN (red), and DAPI staining (blue). C Representative images of 8-month-old control and transgenic animals. Scale bar 20 μm. D . Quantification of GLUT3 mean fluorescence intensity in brain tissue. Quantification of relative fluorescent intensity showed a decrease of GLUT3 in transgenic animals (8-months old animals: CN: 25.07 ± 1.43, Tg: 20.91 ± 0.54; p = 0.035; 10-month-old animals: CN: 28.37 ± 1.03, Tg: 22.36 ± 1.67; p = 0.022; n = 5; mean ± SD, student’s t-test with p-value). E Changes of long-chain, hydroxylated, short-chain ACs and free carnitine in brain tissue of control and transgenic rats (data are presented as median intensities with 95% confidence intervals)

    Techniques Used: Immunofluorescence, Staining, Transgenic Assay, Fluorescence



    Similar Products

    polyclonal rabbit anti-glut3 primary antibody  (Thermo Fisher)
    90
    Thermo Fisher polyclonal rabbit anti-glut3 primary antibody
    Tau pathology switches the energy metabolism to fatty acid oxidation. A-B Immunofluorescence staining of neuron-specific <t>glucose</t> <t>transporter</t> <t>3</t> <t>(GLUT3)</t> in the medulla oblongata from control and transgenic animals. Representative images of GLUT3 (green), NeuN (red), and DAPI staining (blue). C Representative images of 8-month-old control and transgenic animals. Scale bar 20 μm. D . Quantification of GLUT3 mean fluorescence intensity in brain tissue. Quantification of relative fluorescent intensity showed a decrease of GLUT3 in transgenic animals (8-months old animals: CN: 25.07 ± 1.43, Tg: 20.91 ± 0.54; p = 0.035; 10-month-old animals: CN: 28.37 ± 1.03, Tg: 22.36 ± 1.67; p = 0.022; n = 5; mean ± SD, student’s t-test with p-value). E Changes of long-chain, hydroxylated, short-chain ACs and free carnitine in brain tissue of control and transgenic rats (data are presented as median intensities with 95% confidence intervals)
    Polyclonal Rabbit Anti Glut3 Primary Antibody, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/polyclonal rabbit anti-glut3 primary antibody/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    polyclonal rabbit anti-glut3 primary antibody - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    polyclonal rabbit anti glut3 primary antibody  (Thermo Fisher)
    86
    Thermo Fisher polyclonal rabbit anti glut3 primary antibody
    A-B Immunofluorescence staining of neuron-specific <t>glucose</t> <t>transporter</t> <t>3</t> <t>(GLUT3).</t> Representative images of GLUT3 (green), NeuN (red), and DAPI staining in brain tissue from control and transgenic animals. C Representative images of 8-month-old control and transgenic animals. Scale bar 20 µm. D . Quantification of GLUT3 mean fluorescence intensity in brain tissue. Quantification of relative fluorescent intensity showed a decrease of GLUT3 in transgenic animals (8-months old animals: CN: 25.07 ± 1.43, Tg: 20.91 ± 0.54; p= 0.035; 10-month-old animals: CN: 28.37 ± 1.03, Tg: 22.36 ± 1.67; p= 0.022; n= 5; mean ± SD, student’s t-test with p-value). E Changes of long-chain, hydroxylated, short-chain ACs and free carnitine in brain tissue of control and transgenic rats (data are presented as median intensities with 95% confidence intervals).
    Polyclonal Rabbit Anti Glut3 Primary Antibody, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/polyclonal rabbit anti glut3 primary antibody/product/Thermo Fisher
    Average 86 stars, based on 1 article reviews
    polyclonal rabbit anti glut3 primary antibody - by Bioz Stars, 2026-03
    86/100 stars
    		  Buy from Supplier

    Image Search Results


    Tau pathology switches the energy metabolism to fatty acid oxidation. A-B Immunofluorescence staining of neuron-specific glucose transporter 3 (GLUT3) in the medulla oblongata from control and transgenic animals. Representative images of GLUT3 (green), NeuN (red), and DAPI staining (blue). C Representative images of 8-month-old control and transgenic animals. Scale bar 20 μm. D . Quantification of GLUT3 mean fluorescence intensity in brain tissue. Quantification of relative fluorescent intensity showed a decrease of GLUT3 in transgenic animals (8-months old animals: CN: 25.07 ± 1.43, Tg: 20.91 ± 0.54; p = 0.035; 10-month-old animals: CN: 28.37 ± 1.03, Tg: 22.36 ± 1.67; p = 0.022; n = 5; mean ± SD, student’s t-test with p-value). E Changes of long-chain, hydroxylated, short-chain ACs and free carnitine in brain tissue of control and transgenic rats (data are presented as median intensities with 95% confidence intervals)

    Journal: Journal of Neuroinflammation

    Article Title: Changes in lipid metabolism track with the progression of neurofibrillary pathology in tauopathies

    doi: 10.1186/s12974-024-03060-4

    Figure Lengend Snippet: Tau pathology switches the energy metabolism to fatty acid oxidation. A-B Immunofluorescence staining of neuron-specific glucose transporter 3 (GLUT3) in the medulla oblongata from control and transgenic animals. Representative images of GLUT3 (green), NeuN (red), and DAPI staining (blue). C Representative images of 8-month-old control and transgenic animals. Scale bar 20 μm. D . Quantification of GLUT3 mean fluorescence intensity in brain tissue. Quantification of relative fluorescent intensity showed a decrease of GLUT3 in transgenic animals (8-months old animals: CN: 25.07 ± 1.43, Tg: 20.91 ± 0.54; p = 0.035; 10-month-old animals: CN: 28.37 ± 1.03, Tg: 22.36 ± 1.67; p = 0.022; n = 5; mean ± SD, student’s t-test with p-value). E Changes of long-chain, hydroxylated, short-chain ACs and free carnitine in brain tissue of control and transgenic rats (data are presented as median intensities with 95% confidence intervals)

    Article Snippet: Sections were incubated overnight in a polyclonal rabbit anti-IBA-1 primary antibody (1:1000, Wako), polyclonal rabbit anti-GLUT3 primary antibody (1:100, Invitrogen, Massachusetts, USA), and monoclonal mouse anti-NeuN primary antibody (1:1000, Abcam, Waltham, MA, USA).

    Techniques: Immunofluorescence, Staining, Transgenic Assay, Fluorescence

    A-B Immunofluorescence staining of neuron-specific glucose transporter 3 (GLUT3). Representative images of GLUT3 (green), NeuN (red), and DAPI staining in brain tissue from control and transgenic animals. C Representative images of 8-month-old control and transgenic animals. Scale bar 20 µm. D . Quantification of GLUT3 mean fluorescence intensity in brain tissue. Quantification of relative fluorescent intensity showed a decrease of GLUT3 in transgenic animals (8-months old animals: CN: 25.07 ± 1.43, Tg: 20.91 ± 0.54; p= 0.035; 10-month-old animals: CN: 28.37 ± 1.03, Tg: 22.36 ± 1.67; p= 0.022; n= 5; mean ± SD, student’s t-test with p-value). E Changes of long-chain, hydroxylated, short-chain ACs and free carnitine in brain tissue of control and transgenic rats (data are presented as median intensities with 95% confidence intervals).

    Journal: bioRxiv

    Article Title: Changes in lipid metabolism track with the progression of neurofibrillary pathology in tauopathies

    doi: 10.1101/2023.09.05.556321

    Figure Lengend Snippet: A-B Immunofluorescence staining of neuron-specific glucose transporter 3 (GLUT3). Representative images of GLUT3 (green), NeuN (red), and DAPI staining in brain tissue from control and transgenic animals. C Representative images of 8-month-old control and transgenic animals. Scale bar 20 µm. D . Quantification of GLUT3 mean fluorescence intensity in brain tissue. Quantification of relative fluorescent intensity showed a decrease of GLUT3 in transgenic animals (8-months old animals: CN: 25.07 ± 1.43, Tg: 20.91 ± 0.54; p= 0.035; 10-month-old animals: CN: 28.37 ± 1.03, Tg: 22.36 ± 1.67; p= 0.022; n= 5; mean ± SD, student’s t-test with p-value). E Changes of long-chain, hydroxylated, short-chain ACs and free carnitine in brain tissue of control and transgenic rats (data are presented as median intensities with 95% confidence intervals).

    Article Snippet: Sections were incubated overnight in a polyclonal rabbit anti-IBA-1 primary antibody (1:1000, Wako), polyclonal rabbit anti-GLUT3 primary antibody (1:100, Invitrogen, Massachusetts, USA), and monoclonal mouse anti-NeuN primary antibody (1:1000, Abcam, Waltham, MA, USA).

    Techniques: Immunofluorescence, Staining, Transgenic Assay, Fluorescence